Item 2.02 Results of Operations and Financial Condition
On
Although it has not finalized its full financial results for the fourth quarter
and fiscal year ended
The information contained in Item 2.02 of this Form 8-K is unaudited and
preliminary and does not present all information necessary for an understanding
of the Company's financial condition as of
The information in this Item 2.02 is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the "Securities Act"), or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Item 9.01. Exhibits (d) Exhibits Exhibit No. Description 99.1 Press release issued byKymera Therapeutics, Inc. onJanuary 12, 2021 , furnished herewith.
--------------------------------------------------------------------------------
© Edgar Online, source